PRECOS Showcased Preclinical Oncology Service Portfolio at the American Association for Cancer Research Annual Meeting 2013
5/1/2013 11:30:37 AM
More...
|
PRECOS Launch Portfolio of Techniques and Models of Acquired Resistance to Targeted Agents and Standards of Care Used in Oncology at American Association for Cancer Research Annual Meeting 2013
5/1/2013 11:28:14 AM
More...
|
ATLAB Pharma SAS Release: PSMA Imaging as Predictive Biomarker for Anti-PSMA Radioimmunotherapy in mCRPC Patients Presented at American Association for Cancer Research 2013
4/11/2013 11:32:44 AM
More...
|
AEterna Zentaris (AEZS) Presents Encouraging Updated Data on its LHRH Receptor-Targeted Disorazol Z Cytotoxic Conjugates at American Association for Cancer Research Meeting
4/11/2013 7:57:11 AM
More...
|
Nodality, Inc. Announces Data Presentations at American Association for Cancer Research 2013 Annual Meeting
4/11/2013 6:58:36 AM
More...
|
Emergent BioSolutions (EBS) Announces Positive Preclinical Efficacy and PK Data for its New Bispecific Adaptir Protein Therapeutic ES414 at American Association for Cancer Research
4/11/2013 6:57:33 AM
More...
|
Investigators from Duke University Cancer Center Present Results from Precision Biologics Phase I Clinical Study Utilizing the Novel Antibody, NPC-1C (ensituximab) at American Association for Cancer Research’s 2013 Annual Symposium
4/11/2013 6:47:11 AM
More...
|
AEterna Zentaris (AEZS) Presents Encouraging Updated Data on Its LHRH Receptor-Targeted Disorazol Z Cytotoxic Conjugates at American Association for Cancer Research Meeting
4/10/2013 2:27:58 PM
More...
|
Data Presented at American Association for Cancer Research Annual Meeting Support Targeted Immune Reactivation Mechanism and Potential of Peregrine Pharmaceuticals, Inc. (PPHM)'s Bavituximab in Solid Tumor Therapy
4/10/2013 11:57:19 AM
More...
|
Tekmira Pharmaceuticals Corporation's Collaborators at the National Cancer Institute Present Preclinical Data at the Annual Meeting of the American Association for Cancer Research (AACR)
4/10/2013 11:23:04 AM
More...
|
|